AtriCure (ATRC) EBIAT (2016 - 2025)
Historic EBIAT for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$267000.0.
- AtriCure's EBIAT rose 9660.0% to -$267000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.8 million, marking a year-over-year increase of 2607.21%. This contributed to the annual value of -$44.7 million for FY2024, which is 4684.93% down from last year.
- As of Q3 2025, AtriCure's EBIAT stood at -$267000.0, which was up 9660.0% from -$6.2 million recorded in Q2 2025.
- In the past 5 years, AtriCure's EBIAT ranged from a high of $97.1 million in Q3 2021 and a low of -$16.9 million during Q1 2021
- Its 5-year average for EBIAT is -$4.5 million, with a median of -$9.1 million in 2023.
- Per our database at Business Quant, AtriCure's EBIAT skyrocketed by 206217.42% in 2021 and then tumbled by 13474.82% in 2023.
- Over the past 5 years, AtriCure's EBIAT (Quarter) stood at -$13.7 million in 2021, then soared by 69.65% to -$4.2 million in 2022, then crashed by 134.75% to -$9.8 million in 2023, then tumbled by 59.04% to -$15.6 million in 2024, then skyrocketed by 98.28% to -$267000.0 in 2025.
- Its EBIAT stands at -$267000.0 for Q3 2025, versus -$6.2 million for Q2 2025 and -$6.7 million for Q1 2025.